Latest Breaking News On - Geneone life science inc - Page 8 : comparemela.com

INO-4800 COVID-19 Vaccine Description INO-4800 is a DNA vaccine candidate matched to the novel coronavirus SARS-CoV-2, which causes the COVID-19 disease in humans.  INOVIO s INO-4800 is the only nucleic-acid-based vaccine stable at room temperature for more than a year and does not require frozen transport or for years of storage, which are important factors when implementing mass immunizations to battle the current pandemic, says INOVIO. The INO-4800 vaccine contains the plasmid pGX9501, which encodes for the entire length of the Spike glycoprotein of SARS-CoV-2. Inovio s proprietary platform hand-held smart device called CELLECTRA® leads the way forward for activation immunotherapy. CELLECTRA uses a brief electrical pulse to open small pores in the cell reversibly to allow the plasmids to enter.

United statesSoult ukpyolsiSouth koreaMontgomery countyHong kongUniversity of pennsylvaniaBlue bellMacau generalRepublic of koreaInovio covidJeff richardsonKate broderickKaneka eurogentecJ joseph kimSeoul national university hospitalUs department of defense